Significant Advances for Scalp Cooling Treatment Under Medicare
Cooler Heads, a pioneering health technology company, marks a transformative moment in the realm of scalp cooling for chemotherapy patients. This groundbreaking step, influenced by the new 2026 Medicare Physician Fee Schedule Proposed Rule, introduces three new Category I CPT codes dedicated to mechanical scalp cooling treatments, each with newly proposed payment rates.
Enhancing Patient Care with New Reimbursements
This recent development is a milestone as it is the inaugural inclusion of scalp cooling services in the Medicare Physician Fee Schedule. This move establishes a foundation for consistent reimbursement practices, directly benefiting patients facing the distressing side effects of chemotherapy-related hair loss.
Understanding the New CPT Codes
The Centers for Medicare & Medicaid Services (CMS) has proposed payment rates for the newly established codes. The initial CPT code addresses the fitting of the scalp cooling cap and patient education, which would be reimbursed at $1,701. Following this, the second code covers the pre-infusion cooling period, proposed at $10 per treatment. The last code involves the post-infusion cooling period, reimbursed at $6 for each 30-minute increment.
The Importance of Mechanical Scalp Cooling
The newly introduced CPT codes specifically focus on mechanical scalp cooling solutions, leaving out manual cold caps. This distinction lends importance to FDA-cleared systems such as Amma™. The establishment of these codes also motivates private insurance companies to formulate their coverage policies, increasing overall treatment accessibility for patients.
A Growing Future for Cancer Patients
As the public comment period closes on September 12, 2025, there will be updates to ensure the most effective rules are implemented. CMS is anticipated to release the Final Rule in November 2025, with the updated Medicare Physician Fee Schedule and codes becoming effective on January 1, 2026.
Impact on Healthcare Collaboration
This timeline presents an opportunity for Cooler Heads to strengthen collaborations with various health systems, enabling them to broaden the reach of scalp cooling treatments. Such advancements will not only enhance patient care but also elevate the quality of life for those undergoing cancer treatments.
Why Choose Cooler Heads?
Cooler Heads is dedicated to delivering evidence-based products and resources aimed at alleviating the challenges faced by cancer patients. Founded by a survivor, the company’s mission is to mitigate both the physical and emotional burdens of cancer treatment. Through innovative tools like Amma, Cooler Heads strives to ensure patients maintain their identity and dignity throughout their treatment journey.
Frequently Asked Questions
What are the new CPT codes introduced for scalp cooling?
The new CPT codes pertain to the fitting of scalp cooling devices, pre-infusion cooling, and post-infusion cooling treatments, each with specific reimbursement rates.
What is Cooler Heads' mission?
Cooler Heads aims to reduce the challenges of cancer treatment by providing effective products and support systems for patients undergoing therapy.
How will these changes impact patients?
This initiative will enhance access to scalp cooling treatments, ensuring patients can preserve their hair and identity during chemotherapy.
Is this the first time scalp cooling is covered by Medicare?
Yes, this is the first time that scalp cooling treatments have been included in the Medicare Physician Fee Schedule, marking a significant advance for patient care.
What makes mechanical scalp cooling preferable?
Mechanical scalp cooling addresses hair preservation effectively and is supported by the FDA, providing reliable results that manual systems may not offer.
